240 related articles for article (PubMed ID: 25162674)
1. Increased levels of C-C chemokine RANTES in asbestos exposed workers and in malignant mesothelioma patients from an hyperendemic area.
Comar M; Zanotta N; Bonotti A; Tognon M; Negro C; Cristaudo A; Bovenzi M
PLoS One; 2014; 9(8):e104848. PubMed ID: 25162674
[TBL] [Abstract][Full Text] [Related]
2. Chemokines involved in the early inflammatory response and in pro-tumoral activity in asbestos-exposed workers from an Italian coastal area with territorial clusters of pleural malignant mesothelioma.
Comar M; Zanotta N; Zanconati F; Cortale M; Bonotti A; Cristaudo A; Bovenzi M
Lung Cancer; 2016 Apr; 94():61-7. PubMed ID: 26973208
[TBL] [Abstract][Full Text] [Related]
3. Circulating microRNAs found dysregulated in ex-exposed asbestos workers and pleural mesothelioma patients as potential new biomarkers.
Bononi I; Comar M; Puozzo A; Stendardo M; Boschetto P; Orecchia S; Libener R; Guaschino R; Pietrobon S; Ferracin M; Negrini M; Martini F; Bovenzi M; Tognon M
Oncotarget; 2016 Dec; 7(50):82700-82711. PubMed ID: 27716620
[TBL] [Abstract][Full Text] [Related]
4. Peripheral Blood DNA Methylation as Potential Biomarker of Malignant Pleural Mesothelioma in Asbestos-Exposed Subjects.
Guarrera S; Viberti C; Cugliari G; Allione A; Casalone E; Betti M; Ferrante D; Aspesi A; Casadio C; Grosso F; Libener R; Piccolini E; Mirabelli D; Dianzani I; Magnani C; Matullo G
J Thorac Oncol; 2019 Mar; 14(3):527-539. PubMed ID: 30408567
[TBL] [Abstract][Full Text] [Related]
5. DHEA-S, Androstenedione, 17-β-estradiol signature as novel biomarkers for early prediction of risk of malignant pleural mesothelioma linked to asbestos-exposure: A preliminary investigation.
Nuvoli B; Sacconi A; Bottillo G; Sciarra F; Libener R; Maconi A; Carosi M; Piperno G; Mastropasqua E; Papale M; Camera E; Galati R
Biomed Pharmacother; 2024 Jun; 175():116662. PubMed ID: 38692064
[TBL] [Abstract][Full Text] [Related]
6. Significance of serum mesothelin in an asbestos-exposed population in the Czech Republic.
Jakubec P; Pelclova D; Smolkova P; Kolek V; Nakladalova M
Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2015 Sep; 159(3):472-9. PubMed ID: 24781044
[TBL] [Abstract][Full Text] [Related]
7. SV40 multiple tissue infection and asbestos exposure in a hyperendemic area for malignant mesothelioma.
Comar M; Rizzardi C; de Zotti R; Melato M; Bovenzi M; Butel JS; Campello C
Cancer Res; 2007 Sep; 67(18):8456-9. PubMed ID: 17875683
[TBL] [Abstract][Full Text] [Related]
8. Chemokine (C-C motif) ligand 3 detection in the serum of persons exposed to asbestos: A patient-based study.
Xu J; Alexander DB; Iigo M; Hamano H; Takahashi S; Yokoyama T; Kato M; Usami I; Tokuyama T; Tsutsumi M; Tamura M; Oguri T; Niimi A; Hayashi Y; Yokoyama Y; Tonegawa K; Fukamachi K; Futakuchi M; Sakai Y; Suzui M; Kamijima M; Hisanaga N; Omori T; Nakae D; Hirose A; Kanno J; Tsuda H
Cancer Sci; 2015 Jul; 106(7):825-32. PubMed ID: 25940505
[TBL] [Abstract][Full Text] [Related]
9. Changes of mesothelin and osteopontin levels over time in formerly asbestos-exposed power industry workers.
Felten MK; Khatab K; Knoll L; Schettgen T; Müller-Berndorff H; Kraus T
Int Arch Occup Environ Health; 2014 Feb; 87(2):195-204. PubMed ID: 23423281
[TBL] [Abstract][Full Text] [Related]
10. Asbestos and SV40 in malignant pleural mesothelioma from a hyperendemic area of north-eastern Italy.
Comar M; Zanotta N; Pesel G; Visconti P; Maestri I; Rinaldi R; Crovella S; Cortale M; De Zotti R; Bovenzi M
Tumori; 2012; 98(2):210-4. PubMed ID: 22677986
[TBL] [Abstract][Full Text] [Related]
11. Prediagnostic detection of mesothelioma by circulating calretinin and mesothelin - a case-control comparison nested into a prospective cohort of asbestos-exposed workers.
Johnen G; Burek K; Raiko I; Wichert K; Pesch B; Weber DG; Lehnert M; Casjens S; Hagemeyer O; Taeger D; Brüning T;
Sci Rep; 2018 Sep; 8(1):14321. PubMed ID: 30254313
[TBL] [Abstract][Full Text] [Related]
12. [Not Available].
Barbieri PG; Sommigliana AB
Med Lav; 2016 Jul; 107(4):315-26. PubMed ID: 27464904
[TBL] [Abstract][Full Text] [Related]
13. A molecular epidemiology case control study on pleural malignant mesothelioma.
Bolognesi C; Martini F; Tognon M; Filiberti R; Neri M; Perrone E; Landini E; Canessa PA; Ivaldi GP; Betta P; Mutti L; Puntoni R
Cancer Epidemiol Biomarkers Prev; 2005 Jul; 14(7):1741-6. PubMed ID: 16030111
[TBL] [Abstract][Full Text] [Related]
14. A liquid biopsy for detecting circulating mesothelial precursor cells: A new biomarker for diagnosis and prognosis in mesothelioma.
Duong BTV; Wu L; Green BJ; Bavaghar-Zaeimi F; Wang Z; Labib M; Zhou Y; Cantu FJP; Jeganathan T; Popescu S; Pantea J; de Perrot M; Kelley SO
EBioMedicine; 2020 Nov; 61():103031. PubMed ID: 33045471
[TBL] [Abstract][Full Text] [Related]
15. Does Simian Virus 40 (SV40) Have a Role in UK Malignant Pleural Mesothelioma? No Role is Identified in a Sensitive RNA In Situ Hybridization Study on Potentially Affected Birth Cohorts.
Alchami FS; Attanoos RL; Gibbs A; Morgan F; Jasani B
Appl Immunohistochem Mol Morphol; 2020 Jul; 28(6):444-447. PubMed ID: 31205069
[TBL] [Abstract][Full Text] [Related]
16. Is soluble mesothelin-related protein an upfront predictive marker of pleural mesothelioma? A prospective study on Italian workers exposed to asbestos.
Filiberti R; Marroni P; Spigno F; Merlo DF; Mortara V; Caruso P; Cioè A; Michelazzi L; Bruzzone A; Bobbio B; Simonassi C; Del Corso L; Galli R; Racchi O; Dini G; Linares R; Mencoboni M
Oncology; 2014; 86(1):33-43. PubMed ID: 24401539
[TBL] [Abstract][Full Text] [Related]
17. Serum biomarkers in patients with mesothelioma and pleural plaques and healthy subjects exposed to naturally occurring asbestos.
Bayram M; Dongel I; Akbaş A; Benli I; Akkoyunlu ME; Bakan ND
Lung; 2014 Feb; 192(1):197-203. PubMed ID: 24170217
[TBL] [Abstract][Full Text] [Related]
18. Combined circulating epigenetic markers to improve mesothelin performance in the diagnosis of malignant mesothelioma.
Santarelli L; Staffolani S; Strafella E; Nocchi L; Manzella N; Grossi P; Bracci M; Pignotti E; Alleva R; Borghi B; Pompili C; Sabbatini A; Rubini C; Zuccatosta L; Bichisecchi E; Valentino M; Horwood K; Comar M; Bovenzi M; Dong LF; Neuzil J; Amati M; Tomasetti M
Lung Cancer; 2015 Dec; 90(3):457-64. PubMed ID: 26431916
[TBL] [Abstract][Full Text] [Related]
19. SV40 enhances the risk of malignant mesothelioma among people exposed to asbestos: a molecular epidemiologic case-control study.
Cristaudo A; Foddis R; Vivaldi A; Buselli R; Gattini V; Guglielmi G; Cosentino F; Ottenga F; Ciancia E; Libener R; Filiberti R; Neri M; Betta P; Tognon M; Mutti L; Puntoni R
Cancer Res; 2005 Apr; 65(8):3049-52. PubMed ID: 15833832
[TBL] [Abstract][Full Text] [Related]
20. Mesothelin promoter variants are associated with increased soluble mesothelin-related peptide levels in asbestos-exposed individuals.
De Santi C; Pucci P; Bonotti A; Melaiu O; Cipollini M; Silvestri R; Vymetalkova V; Barone E; Paolicchi E; Corrado A; Lepori I; Dell'Anno I; Pellè L; Vodicka P; Mutti L; Foddis R; Cristaudo A; Gemignani F; Landi S
Occup Environ Med; 2017 Jun; 74(6):456-463. PubMed ID: 28343162
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
